M&A Deal Summary |
|
|---|---|
| Date | 2019-12-04 |
| Target | Visiomed Group SA - Family Health Activities |
| Sector | Medical Products |
| Buyer(s) | Biosynex |
| Sellers(s) | Klea Holding |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2005 |
| Sector | Life Science |
| Employees | 176 |
| Revenue | 27M EUR (2016) |
Biosynex is a designer and distribution of rapid diagnostic tests. Biosynex develops, manufactures and markets Medical Devices for Screening, Diagnostics, and Prevention in a permanent quest for excellence. Biosynex was founded in 2008 and is based in Illkirch-Graffenstaden, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 5 |
| Sector: Medical Products M&A | 1 of 4 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 3 |
| Year: 2019 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-03 |
AVALUN
Grenoble, France AVALUN is a manufacturer of medical devices. LabPad+ is a smartphone/tablet application that connects via Bluetooth to AVALUN’s LabPad devices. Once connected, LabPad+ allows performing a biological test by associating to the result all the useful traceability information concerning the test performed, the operator, the patient, and any contextual comments. AVALUN is based in Grenoble, France. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 2007 |
| Sector | Medical Products |
| Employees | 118 |
| Revenue | 17M EUR (2024) |
Klea Holding manufactures and distributes electronic and parapharmaceutical products in 5 ranges (thermometers, blood pressure, electrotherapy, health & well-being, and oral hygiene). Klea Holding was founded in 2007 and is based in Paris, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 1 |
